A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option
2014 ◽
Vol 136
(12)
◽
pp. 2940-2948
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 28
(4)
◽
pp. 1105-1109
◽
1995 ◽
Vol 32
◽
pp. 114
Keyword(s):
1989 ◽
Vol 47
(8)
◽
pp. 5
Keyword(s):
2017 ◽
Vol 46
◽
pp. 144
◽
Keyword(s):
Keyword(s):